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Presence of pre-diabetes in Helicobacter pylori positive versus Helicobacter pylori
negative patients having dyspepsia
Davide Giuseppe Ribaldone, Sharmila Fagoonee
We have read with great interest the article by Draz et al,
reporting the prevalence of Helicobacter pylori (H. pylori)
infection, in patients with dyspepsia and pre-diabetic
status. The authors found that 58.5% of patients with H.
pylori infection versus 45.9% (p=0.03) of patients without
H. pylori had pre-diabetes. The method used to diagnose
H. pylori infection was the histology based on bioptic
samples taken in antrum during gastroscopy.1 This latter
point raises a crucial criticism. When a patient needs a
gastroscopy, due to alarming symptoms or older age
(generally >45 years, but age should be determined locally
according to gastric cancer risk), H. pylori infection can be
detected on biopsies taken in the stomach from two
topographical locations, the antrum and the corpus. Since
the inherent risk of any biopsy procedure is sampling
error, to biopsy both gastric compartments (two biopsies
from the antrum and two from the corpus) increases the
test's sensitivity, especially if the patient was recently
treated with a proton pump inhibitor drug.2 When
gastroscopy is not mandatory, C-urea breath test (UBT) is
the most accurate tool to detect H. pylori infection and is
more cost-effective than endoscopy. This method is based
on the principle that, in the presence of H. pylori urease,
labelled carbon dioxide is exhaled in the expired breath.
In contrast to biopsy-based tests, UBT is not liable to
sampling errors (it tests the entire stomach).2
Thus, although the findings of Draz et al agree with a large
series of studies,3 the accuracy of their findings could be
increased avoiding the risk of false-negative results due
to the limited area of stomach investigated for H. pylori
infection.
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